Examkin

Soru

Zorluk: Çok zorOrdering Imaging Studies

A 68-year-old man presents to the clinic with a 2-week history of painless, visible blood in his urine. He reports no dysuria, frequency, flank pain, or fever. He has a 40-pack-year smoking history and continues to smoke one pack a day. Medical history is significant for severe chronic kidney disease secondary to hypertensive nephrosclerosis (baseline creatinine 3.2 mg/dL, estimated glomerular filtration rate 18 mL/min/1.73 m²), type 2 diabetes mellitus, and a legacy dual-chamber pacemaker placed 12 years ago for sick sinus syndrome. Vital signs are normal. Physical examination reveals no costovertebral angle tenderness, and the abdomen is soft and non-tender without palpable masses. Urinalysis confirms >50 red blood cells/high-power field and no leukocyte esterase, nitrites, or bacteria. The patient is scheduled for cystoscopy next week to evaluate the lower urinary tract. Which of the following is the most appropriate imaging strategy to evaluate this patient's upper urinary tract?

  1. A
    Computed tomography urography
  2. B
    Magnetic resonance urography
  3. Non-contrast computed tomography of the abdomen and pelvis combined with retrograde pyelographyCevap
  4. D
    Non-contrast computed tomography of the abdomen and pelvis alone
  5. E
    Renal and bladder ultrasonography

Cevap

The most appropriate strategy is non-contrast computed tomography of the abdomen and pelvis combined with retrograde pyelography.
High-risk patients with gross hematuria require complete evaluation of the upper urinary tracts. The gold standard is computed tomography urography (CTU), but this patient's severe CKD (eGFR 18) poses an unacceptably high risk for contrast-induced nephropathy. Magnetic resonance urography (MRU) is the standard alternative, but this is contraindicated due to his legacy pacemaker and the severe CKD (gadolinium risk for nephrogenic systemic fibrosis). Therefore, the safest and most comprehensive alternative is a non-contrast CT (to evaluate for renal parenchymal masses and radiopaque urolithiasis) combined with retrograde pyelography. Retrograde pyelography uses fluoroscopy and contrast injected directly into the ureters via cystoscopy. Because the contrast is not absorbed systemically, it avoids nephrotoxicity while thoroughly evaluating the urothelial lining for tumors.

Adım Adım Çözüm

1
Identify the primary clinical problem and required diagnostic workup.
The patient has painless gross hematuria with high-risk features for malignancy (age >60, 40-pack-year smoking history). This requires evaluation of the lower urinary tract (cystoscopy) and the upper urinary tract.
Gross hematuria in high-risk patients has a significant association with urologic malignancies, specifically urothelial carcinoma and renal cell carcinoma.
2
Determine the gold standard imaging test for upper tract evaluation.
Computed tomography urography (CTU) is the gold standard.
CTU provides a multiphasic evaluation (non-contrast, nephrographic, and excretory phases) to assess for both parenchymal masses and urothelial lesions.
3
Evaluate patient-specific contraindications to standard imaging modalities.
CTU is contraindicated due to severe chronic kidney disease (eGFR 18 mL/min/1.73 m²), which presents an unacceptable risk of contrast-induced nephropathy.
Intravenous iodinated contrast must be avoided in patients with an eGFR <30 mL/min/1.73 m².
4
Evaluate second-line alternatives and their specific contraindications.
Magnetic resonance urography (MRU) is the standard alternative to CTU, but it is contraindicated here due to the patient's legacy (non-MRI-conditional) pacemaker and the risk of gadolinium-induced nephrogenic systemic fibrosis.
Legacy pacemakers pose thermal injury and displacement risks in MRI scanners. Gadolinium is contraindicated when eGFR <30.
5
Select the appropriate third-line alternative strategy.
A combination of non-contrast CT and retrograde pyelography is selected.
Non-contrast CT evaluates the renal parenchyma for masses and radiopaque stones. Retrograde pyelography (performed during cystoscopy) involves injecting contrast directly into the ureters under fluoroscopy, allowing visualization of the urothelium without systemic contrast absorption.

Anahtar Kavram

Upper urinary tract imaging for gross hematuria in high-risk patients with contraindications to systemic contrast and MRI.
Bu soruyu puanla

Konular

Ordering Imaging Studies

Bu konudan daha fazla soru